Natto Extract · NSK-SD
Nattokinase is a fibrinolytic enzyme isolated from natto (fermented soybeans), a traditional Japanese food. Discovered by Dr. Hiroyuki Sumi in 1987. Active in breaking down fibrin clots - the same protein dissolved by tissue plasminogen activator (tPA) and other thrombolytic drugs.
Starting dose. 2,000 FU daily
Divided AM/PM preferred.
Start here. Every protocol below is ordered lowest-first. Begin at the smallest effective dose, hold about a week to assess tolerance, and step up only if needed.
Nattokinase has fibrinolytic activity:
Hydrolyzes fibrin in clots - same target as tPA but oral bioavailability allows daily prevention rather than acute thrombolysis.
Lowers serum fibrinogen levels - reduces clot-formation potential.
Indirectly enhances endogenous fibrinolytic system.
Modest BP reduction in clinical trials, mechanism unclear (possibly via ACE inhibition).
More acid-stable than serrapeptase, but enteric coating still preferred for full activity.
Days 1-14: subtle effects.
Weeks 4-8: peak BP/fibrinogen reductions.
Long-term continuous use OK.
Each reference below was re-fetched from its PubMed record, and the quoted sentence was confirmed to appear in that abstract and to support the claim it sits under. Follow any of them to read the source.
Evidence boundary from the checked abstract: No notable adverse events were reported in all studies due to intake of nattokinase.
No notable adverse events were reported in all studies due to intake of nattokinase.
Evidence scope. This entry supports only the exact statement quoted from the live abstract; it does not independently verify OnePin's displayed dose, route, frequency, formulation, population, or broader mechanism.
Claims we could not support
No abstract we checked supports these for this molecule at this route. That is not the same as saying they are false — it marks where the evidence is missing.
Dose/route: 2,000 FU daily; Oral capsule; 1-2x daily. No checked live PubMed abstract verified this exact displayed dose, route, and frequency for the same molecule/formulation and relevant population.
Primary safety claim: No primary safety text present in source JSON. No checked live PubMed abstract directly verified this source-JSON safety claim at the displayed formulation, route, and regimen.
Plasma
Post-ingestion
Days for cumulative cardiovascular effects
Oral moderate (~30-50%)
Daily dosing for sustained effects
Hepatic
Storage. Capsule. Cool dry location, refrigerate for extended storage.
Dietary supplement (US, DSHEA). Functional food in Japan.
Put it to work
Open Nattokinase straight into OnePin with your vial and dose pre-filled, then let it handle the syringe math and remind you before the vial runs out.
Open Nattokinase in the app →Go deeper
The complete Nattokinase walkthrough, real protocol discussion and coaching live inside the BlessUp community on Skool.
Join the community ↗Track it in OnePin. Log vials, draws, and protocols in the app.
Type a name, brand, or tool. Esc closes.